Selected article for: "average number and infectious day average number"
Author: Qifang Bi; Yongsheng Wu; Shujiang Mei; Chenfei Ye; Xuan Zou; Zhen Zhang; Xiaojian Liu; Lan Wei; Shaun A Truelove; Tong Zhang; Wei Gao; Cong Cheng; Xiujuan Tang; Xiaoliang Wu; Yu Wu; Binbin Sun; Suli Huang; Yu Sun; Juncen Zhang; Ting Ma; Justin Lessler; Teijian Feng
Title: Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts
  • Document date: 2020_3_4
    • ID: hnx213kp_38
    Snippet: To calculate the potential impact of surveillance and isolation on transmission, we considered a range of possible infectious periods where infectiousness varied over time. We define the mean infectious day (i.e., the average number of days after symptom onset an infector is expected to infect a secondary case) as the weighted mean of the infectious period, where each day is weighted by relative infectiousness. We consider periods where the mean .....
    Document: To calculate the potential impact of surveillance and isolation on transmission, we considered a range of possible infectious periods where infectiousness varied over time. We define the mean infectious day (i.e., the average number of days after symptom onset an infector is expected to infect a secondary case) as the weighted mean of the infectious period, where each day is weighted by relative infectiousness. We consider periods where the mean infectious day is less than 15 days after symptom onset (roughly the period of SARS and early SARS-CoV-2 reports . CC-BY-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • mean infectious day and relative infectiousness: 1
    • mean infectious day and symptom onset: 1
    • period consider and symptom onset: 1, 2
    • potential impact and SARS report: 1, 2
    • potential impact and secondary case: 1
    • potential impact and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8
    • potential impact and time vary: 1
    • potential impact and transmission isolation surveillance: 1
    • potential impact and transmission isolation surveillance potential impact: 1
    • relative infectiousness and secondary case: 1, 2, 3
    • relative infectiousness and symptom onset: 1, 2, 3, 4, 5, 6, 7
    • relative infectiousness and time vary: 1, 2
    • SARS report and secondary case: 1, 2, 3
    • SARS report and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • secondary case and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
    • secondary case and time vary: 1, 2
    • secondary case and weight mean: 1
    • symptom onset and time vary: 1, 2, 3
    • symptom onset and transmission isolation surveillance: 1, 2